The MY PART (Michigan and You Partnering to Advance Research Together) study at Michigan Medicine aims to enroll participants in the Michigan Genomics Initiative from a wide range of backgrounds, ensuring representation across different health and disease statuses. 

The MIPACT study was a research initiative designed to leverage Apple health kit data to explore how lifestyle factors and clinical data can predict health outcomes.

The ImPrec study is a research initiative aimed at improving outcomes for organ transplant recipients by understanding and managing the immune responses involved in transplantation.

MEND is a specialized research effort dedicated to understanding the genetic factors influencing metabolic, endocrine, and diabetes-related conditions.